Literature DB >> 20814218

Macrophages and dendritic cells for treating kidney disease.

Q Cao1, D Zheng, Y P Wang, D C H Harris.   

Abstract

Based on new understanding of the diverse biological functions of macrophages and dendritic cells (DC), the focus of studies on these cells has been expanded from their pathogenic role in renal diseases to include their potential to regulate inflammation and restore renal architecture and function. By exploiting their regulatory function, macrophages or DC have been used to treat experimental renal disease following their adoptive transfer. This review summarizes current progress in the therapeutic use of macrophages and DC in renal diseases. Key issues for ongoing research are discussed.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20814218     DOI: 10.1159/000320595

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  7 in total

1.  Injection of amniotic fluid stem cells delays progression of renal fibrosis.

Authors:  Sargis Sedrakyan; Stefano Da Sacco; Anna Milanesi; Liron Shiri; Astgik Petrosyan; Radka Varimezova; David Warburton; Kevin V Lemley; Roger E De Filippo; Laura Perin
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

2.  C-reactive protein exacerbates renal ischemia-reperfusion injury.

Authors:  Melissa A Pegues; Mark A McCrory; Abolfazl Zarjou; Alexander J Szalai
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-27

Review 3.  Pathogenic and protective role of macrophages in kidney disease.

Authors:  Qi Cao; Yiping Wang; David C H Harris
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-01

Review 4.  Dendritic Cell Dysfunction in Patients with End-stage Renal Disease.

Authors:  Ji Ung Kim; Miyeon Kim; Sinae Kim; Tam Thanh Nguyen; Eunhye Kim; Siyoung Lee; Soohyun Kim; Hyunwoo Kim
Journal:  Immune Netw       Date:  2017-06-20       Impact factor: 6.303

5.  A shift towards pro-inflammatory CD16+ monocyte subsets with preserved cytokine production potential after kidney transplantation.

Authors:  Elly J F Vereyken; Marina D Kraaij; Carla C Baan; Farhad Rezaee; Willem Weimar; Kathryn J Wood; Pieter J M Leenen; Ajda T Rowshani
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

6.  Circulating dendritic cell precursors in chronic kidney disease: a cross-sectional study.

Authors:  Katharina Paul; Daniel Kretzschmar; Atilla Yilmaz; Barbara Bärthlein; Stephanie Titze; Gunter Wolf; Martin Busch
Journal:  BMC Nephrol       Date:  2013-12-10       Impact factor: 2.388

Review 7.  The regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells.

Authors:  Tao Du; Ying-Jian Zhu
Journal:  Mediators Inflamm       Date:  2014-04-15       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.